Exposure to oral methylphenidate from adolescence through young adulthood produces transient effects on hippocampal-sensitive memory in rats

Behavioural Brain Research

Volumn 202, Issue 1, 2009, Pages 50-57

  Bethancourt, José A ^a   Camarena, Zurislay Z ^a   Britton, Gabrielle B ^a,b  

^a INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^b Clínica Neuropsicológica   (Panama)

Author keywords

Cognition; Contextual fear conditioning; Emotion; Methylphenidate; Novel object recognition; Open field; Rat

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ADULTHOOD; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FREEZING; HIPPOCAMPUS; LATENT PERIOD; LEARNING; LONG TERM EXPOSURE; MALE; MEMORY; MEMORY CONSOLIDATION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TREATMENT DURATION; WISTAR RAT;

EID: 67349286238     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.03.015     Document Type: Article

References (63)

1. Abrari K., Rashidy-Pour A., Semnanian S., and Fathollahi Y. Post-training administration of corticosterone enhances consolidation of contextual fear memory and hippocampal long-term potentiation in rats. Neurobiol Learn Mem 91 (2009) 260-265
2. Andersen S.L. Stimulants and the developing brain. Trends Pharmacol Sci 26 (2005) 237-243
3. Bannerman D.M., Rawlins J.N.P., McHugh S.B., Deacon R.M.J., Yee B.K., Bast T., et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 28 (2004) 273-283
4. Bashir Z.I., Alford S., Davies S.N., Randall A.D., and Collingridge G.L. Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus. Nature 349 (1991) 156-158
5. Biederman J., and Faraone S. Attention deficit hyperactivity disorder. Lancet 366 (2005) 237-248
6. Bisagno V., Ferguson D., and Luine V.N. Chronic d-amphetamine induces sexually dimorphic effects on locomotion, recognition memory, and brain monoaminas. Pharm Biochem Behav 74 (2003) 859-867
7. Bolaños C.A., Barrot M., Berton O., Wallace-Black D., and Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54 (2003) 1317-1329
8. Bolaños C.A., Glatt S.J., and Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Brain Res Dev Brain Res 111 (1998) 25-33
9. Bouton M.E., and Bolles R.C. Conditioned fear assessed by freezing and by the suppression of three different baselines. Anim Learn Behav 8 (1980) 429-434
10. Brandon C.L., Marinelli M., and White F.J. Adolescent exposure to methylphenidate alters activity of rat midbrain dopamine neurons. Biol Psychiatry 54 (2003) 1338-1344
11. Brandon C.L., and Steiner H. Repeated methylphenidate treatment in adolescent rats alters gene expression in the striatum. Eur J Neurosci 18 (2003) 1584-1592
12. Britton G.B., and Astheimer L.B. Fear develops to the conditioned stimulus and to the context during classical eyeblink conditioning in rats. Integr Phys Behav Sci 39 (2004) 295-306
13. Britton G.B., Segan A.T., Sejour J., and Mancebo S. Early exposure to methylphenidate increases fear responses in an aversive context in adult rats. Dev Psychobiol 49 (2007) 265-275
14. Broadbent N.J., Squire L.R., and Clark R.E. Spatial memory, recognition memory, and the hippocampus. Proc Nat Acad Sci 101 (2004) 14515-14520
15. Carlezon W.A., Mague S.D., and Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54 (2003) 1330-1337
16. Carrey N., McFayden M.P., and Brown R.E. Effects of subchronic methylphenidate hydrochloride administration on the locomotor and exploratory behavior of prepubertal mice. J Child Adol Psychopharm 10 (2000) 277-286
17. Chuhan Y.S., and Taukulis H.K. Impairment of single-trial memory formation by oral methylphenidate in the rat. Neurobiol Learn Mem 85 (2006) 125-131
18. Deacon R.M.J. Housing, husbandry and handling of rodents for behavioral experiments. Nat Protoc 1 (2006) 936-946
19. Cordero M.I., and Sandi C. A role for brain glucocorticoid receptors in contextual fear conditioning: dependence upon training intensity. Brain Res 786 (1998) 11-17
20. Ennaceur A., and Delacour J. A new one-trial test for neurobiological studies of memory in rats. I. Behavioral data. Behav Brain Res 31 (1988) 47-59
21. Fanselow M.S. Conditional and unconditional components of post-shock freezing. Pav J Biol Sci 15 (1980) 177-182
22. Fanselow M.S. The postshock activity burst. Anim Learn Behav 10 (1982) 448-454
23. Fanselow M.S. Factors governing one trial contextual conditioning. Anim Learn Behav 18 (1990) 264-270
24. Federici M., Geracitano R., Bernardi G., and Mercuri N.B. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain. Biol Psychiatry 57 (2005) 361-365
25. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., et al. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther 295 (2000) 51-57
26. Giedd J.N., Rosenthal M.A., Blythe R.A., Blumenthal J.D., Molloy E., Dopp R.R., et al. Brain development in healthy children and adolescents: magnetic resonance imaging studies. In: Keshavan M.S., Kennedy J.L., and Murray R.M. (Eds). Neurodevelopment and schizophrenia (2004), University Press, New York 35-44
27. Gray J.D., Punsoni M., Tabori N.E., Melton J.T., Fanslow V., Ward M.J., et al. Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress. J Neurosci 27 (2007) 7196-7207
28. Heyser C.J., Pelletier M., and Ferris J.S. The effects of methylphenidate on novel object exploration in weanling and periadolescent rats. Ann NY Acad Sci 1021 (2004) 465-469
29. Hui G.K., Figueroa I.R., Poytress B.S., Roozendaal B., McGaugh J.L., and Weinberger N.M. Memory enhancement of classical fear conditioning by post-training injections of corticosterone in rats. Neurobiol Learn Mem 81 (2004) 67-74
30. Husson I., Mesples B., Medja F., Leroux P., Kosofsky B., and Gressens P. Methylphenidate and MK-801, an N-methyl-d-aspartate receptor antagonist: shared biological properties. Neuroscience 125 (2004) 163-170
31. Kim J.J., and Fanselow M.S. Modality-specific retrograde amnesia of fear. Science 256 (1992) 675-677
32. Kjelstrup K.G., Tuvnes F.A., Steffenach H.A., Murison R., Moser E.I., and Moser M.B. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci USA 99 (2002) 10825-10830
33. Kuczenski R., and Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 296 (2001) 876-883
34. Kuczenski R., and Segal D.S. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22 (2002) 7264-7271
35. Kuczenski R., and Segal D.S. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential for substance abuse. Biol Psychiatry 57 (2005) 1391-1396
36. LeBlanc-Duchin D., and Taukulis H.K. Behavioral reactivity to a noradrenergic challenge after chronic oral methylphenidate (Ritalin) in rats. Pharmacol Biochem Behav 79 (2004) 641-649
37. LeBlanc-Duchin D., and Taukulis H.K. Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects. Neurobiol Learn Mem 88 (2007) 312-320
38. McGaugh J.L. Memory-a century of consolidation. Science 287 (2000) 248-251
39. Moll G.H., Hause S., Rüther E., Rothenberger A., and Huether G. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adol Psychop 11 (2001) 15-24
40. Pastor P.N., and Reuben C.A. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. National Center for Health Statistics. Vital Health Stat 10 (2008) 237
41. Phillips R.G., and LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106 (1992) 274-285
42. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., and Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164 (2007) 942-948
43. Pugh C.R., Fleshner M., and Rudy J.W. Type II glucocorticoid receptor antagonists impair contextual but not auditory cue fear conditioning in juvenile rats. Neurobiol Learn Mem 67 (1997) 75-79
44. Quirk G.J., Russo G.K., Barron J.L., and Lebron K. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci 20 (2000) 6225-6231
45. Scheffler R.M., Hinshaw S.P., Modrek S., and Levine P. The global market for ADHD medications. Health Aff 26 (2007) 450-457
46. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94 (1998) 127-152
47. Spear L.P. The adolescent brain and age-related behavioral manisfestations. Neurosci Biobehav Rev 24 (2000) 417-463
48. Spencer T., Biederman J., Wilens T., Harding M., O'Donnell D., and Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35 (1996) 409-432
49. Sproson E.J., Chantrey J., Hollis C., Marsden C.A., and Fone K.C.F. Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats. J Psychopharmacol 15 (2001) 67-75
50. Swanson J.M., Sergeant J., Taylor E., Sonuga-Barke E.J.S., Jensen P., and Cantwell D. Attention deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351 (1998) 429-433
51. Swanson J.M., and Volkow N.D. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 27 (2003) 615-621
52. Thanos P.K., Michaelides M., Benveniste H., Wang G.J., and Volkow N.D. Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharm Biochem Behav 87 (2007) 426-433
53. Thiel C.M., Muller C.P., Huston J.P., and Schwarting R.K. High versus low reactivity to a novel environment: behavioural, pharmacological and neurochemical assessments. Neuroscience 93 (1999) 243-251
54. Thompson B.L., Erickson K., Schulkin J., and Rosen J.B. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav Brain Res 149 (2004) 209-215
55. Tsuda A., Ida Y., Satoh H., Tsujimaru S., and Tanaka M. Stressor predictability and rat brain noradrenaline metabolism. Pharm Biochem Behav 32 (1989) 569-572
56. Vianna M.R., Alonso M., Viola H., Quevedo J., de Paris F., Furman M., et al. Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem 7 (2000) 333-340
57. Volkow N.D., and Insel T.R. What are the long-term effects of methylphenidate treatment?. Biol Psychiatry 54 (2003) 1307-1309
58. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155 (1998) 1325-1331
59. Wheeler T.L., Eppolito A.K., Smith L.N., Huff T.B., and Smith R.F. A novel method for oral stimulant administration in the neonate rat and similar species. J Neurosci Methods 159 (2007) 282-285
60. Yang P., Swann A., and Dafny N. NMDA receptor antagonist disrupts acute and chronic effects of methylphenidate. Physiol Behav 71 (2000) 133-145
61. Yang P.B., Swann A.C., and Dafny N. Acute and chronic methylphenidate dose response assessment on three adolescent male rat strains. Brain Res Bull 71 (2006) 301-310
62. Zeise M.L., Espinoza S., González A., Cerda F.S., Nacarate J., Yáñez C.G., et al. Methylphenidate improves cue navigation in the Morris water maze in rats. NeuroReport 18 (2007) 1059-1062
63. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., and Lynch F. Trends in prescribing of psychotropic medications to preschoolers. J Am Med Assoc 283 (2000) 1025-1030